Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of cyclosporine ophthalmic gel in moderate to severe dry eye
CTR20244551Phase 3Active
- Sponsor
- Zhaoke Ophthalmology
- Start
- Apr 2025
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine in dry eye syndrome (DED), sponsored by Zhaoke Ophthalmology. Started Apr 2025; status: active.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20244551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244551.